AI has the potential to transform life sciences commercialization, but only if we design it around people. Machines bring ...

The near-term outlook for ClearPoint's biopharma business is also now clouded by FDA uncertainty around uniQure's AMT-130.

"Within two days at the hospital, by day three, they called my family to come and say goodbye," she tells PEOPLE ...

Lilly will also gain certain rights to MeiraGTx’s proprietary riboswitch technology for use in gene editing in the eye. Under ...

Ten stocks soared higher on Wednesday, mirroring a broader market rally, as investors continued to take path from a flurry of ...

Accuray's weak quarter signals ongoing challenges despite new CEO plans. Discover key insights and risks before investing in ...

Engineer Paul Salmon leads a movement to make conversational AI more human, empathetic, and trustworthy.

CMS is expanding coverage for remote patient monitoring in its 2026 Medicare Physician Fee Schedule, while a major payer is scaling back reimbursement to two specific use cases.

The MarketWatch News Department was not involved in the creation of this content.-- Third quarter revenue increased 15% year-over-year to $44.2 million -- Commercial Cell & Gene T ...

Students and professors are in a drawn-out battle over grade inflation. It may never end.

Over the past two decades, synthetic biology has fueled advancements across a broad range of disciplines, including agriculture, bioremediation, biofuel production, and chemical manufacturing. Today, ...

Women are finding that when it comes to dating, advice, and listening, AI understands what they need more than the people in ...